We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Fragment-Based Drug Discovery
From Proteopedia
(Difference between revisions)
| Line 11: | Line 11: | ||
| - | <scene name='Sandbox_reserved_394/Bcl-xl/1'>Bcl-xl</scene> is a member of the Bcl-2 family. The protein | + | <scene name='Sandbox_reserved_394/Bcl-xl/1'>Bcl-xl</scene> is a member of the Bcl-2 family. The protein is comprised of seven <scene name='Sandbox_reserved_394/Alpha_helices/1'>alpha helices</scene>, no beta sheets, and 221 amino acid residues. |
==== Bcl-xl Inhibition ==== | ==== Bcl-xl Inhibition ==== | ||
Revision as of 01:20, 3 October 2012
Apoptosis by Inhibition of Bcl-2 Family Proteins
| |||||||||||
References
- ↑ Oltersdorf T., Elmore S.W., Shoemaker A.R. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Vol 435|2 June 2005|doi:10.1038/nature03579
